Showing 261 - 280 results of 1,475 for search '"cancer"', query time: 0.07s Refine Results
  1. 261

    Stool immunoassay for identification of colorectal cancer and other significant gastrointestinal diseases risk groups by N. S. Sergeeva, Nina V. Marshutina, Ye. V. Zenkina

    Published 2016-08-01
    “…Key words: colorectal cancer, stomach cancer, ulcerative colitis, colonic polyps, fecal immunochemical test (FIT), hHb, hHb/Hp, fTu M2-PK.…”
    Get full text
    Article
  2. 262

    Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer by Liangjian Ma, Wunan Huang, Xiaolei Liang, Hongli Li, Wei Yu, Lexin Liu, Yuelin Guan, Chang Liu, Xiangjun Chen, Lidan Hu

    Published 2025-02-01
    “…Abstract Endometrial cancer (EC) is a significant health threat to women, with recurrence after treatment posing a major challenge. …”
    Get full text
    Article
  3. 263
  4. 264
  5. 265

    Comprehensive genomic and transcriptomic profiling of pulmonary nodules in synchronous multiple primary lung cancer by Xingsheng Liu, Kun Qian, Lei Su, Xiaoru Tian, Xin Zhao, Tengteng Wang, Li Han, Zhenzhen Li, Peilong Zhang, Ruotian Wang, Baodong Liu, Yuanbo Li, Xiaogang Tan, Yi Zhang

    Published 2025-02-01
    “…Abstract Background Synchronous multiple primary lung cancer (sMPLC) exhibits distinct histopathological characteristics among pulmonary nodules. …”
    Get full text
    Article
  6. 266
  7. 267
  8. 268
  9. 269

    Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle by Vishnu Kumarasamy, Jianxin Wang, Michelle Roti, Yin Wan, Adam P. Dommer, Hanna Rosenheck, Sivasankar Putta, Alec Trub, John Bisi, Jay Strum, Patrick Roberts, Seth M. Rubin, Costakis Frangou, Karen McLean, Agnieszka K. Witkiewicz, Erik S. Knudsen

    Published 2025-02-01
    “…Abstract Cyclin dependent kinase 2 (CDK2) regulates cell cycle and is an emerging target for cancer therapy. There are relatively small numbers of tumor models that exhibit strong dependence on CDK2 and undergo G1 cell cycle arrest following CDK2 inhibition. …”
    Get full text
    Article
  10. 270

    Improving neuroendocrine tumor treatments with mathematical modeling: lessons from other endocrine cancers by John Metzcar, Rachael Guenter, Yafei Wang, Kimberly M Baker, Kate E Lines

    Published 2025-02-01
    “…Causal or mechanistic mathematical modeling is widely deployed in disease areas such as breast and prostate cancers, aiding the understanding of observations and streamlining in vitro and in vivo modeling efforts. …”
    Get full text
    Article
  11. 271
  12. 272
  13. 273

    Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel by Keith L. Davis, Benjamin Gutierrez, Teresa Zyczynski, James A. Kaye

    Published 2015-01-01
    “…**Background:** Docetaxel has been a standard of care for castration-resistant prostate cancer (CRPC) in the United States since 2004, yet little has been reported on its patterns of use in routine practice. …”
    Get full text
    Article
  14. 274
  15. 275
  16. 276
  17. 277
  18. 278

    A comprehensive analysis of deep learning and transfer learning techniques for skin cancer classification by Manishi Shakya, Ravindra Patel, Sunil Joshi

    Published 2025-02-01
    “…This research focus on skin cancer images and provides solution using deep learning approaches. …”
    Get full text
    Article
  19. 279
  20. 280